2014, Number 2
<< Back Next >>
Rev Cubana Pediatr 2014; 86 (2)
Vascular and renal damage markers observed in urine from obese children and adolescents
Pérez CLM, Herrera VR, Chong LA, Villacís PD, Fernández MI
Language: Spanish
References: 28
Page: 168-178
PDF size: 267.73 Kb.
ABSTRACT
Introduction: microalbuminuria is considered to be a marker of endothelial
dysfunction, vascular damage, renal damage and cardiovascular disease in addition to
be an independent risk factor for morbidity and mortality. Similarly, proteinuria has
been identified as an independent risk factor for chronic renal disease and a predictor
of all causes of mortality. Both are relatively frequent in obese subjects.
Objective: to determine the frequency of vascular and renal markers in the urine
from obese children and adolescents.
Methods: prospective, observational and analytical study of obese children and
adolescents seen at the reference service called obesity and kidney in the teaching
pediatric hospital of Centro Habana. The study was conducted from January 2009
through December 2012. Vascular and renal markers were determined in the urine
(microalbuminuria and proteinuria). The statistical analysis was based on SPSS
program version 13.0.
Results: there was just one patient detected with proteinuria (0.5 %); however, in
the microalbuminuria test, it was found that over half of the patients (70.8 %) were
positive to this vascular and renal damage marker. In the histopathological analysis of
the renal biopsy taken from the patient with proteinuria, segmental glomerulosclerosis
and adhesion to Bowman's capsule was discovered.
Conclusions: obese children and adolescents have very frequent positivity to
vascular and renal damage markers, mainly microalbuminuria.
REFERENCES
Tsioufis C, Mazaraki A, Dimitriadis K, Stefanidis C, Stefanadis C. Microalbuminuria in the pediatric age: current knowledge and emerging Questions. Acta Pediatrica. Foundation Acta Pediatrica. 2011;100:1180-4.
Habbal R, Sekhri AR, Volpe M. Prevalence of microalbuminuria in hypertensive patients and its associated cardiovascular risk in clinical cardiology: Moroccan results of the global In search survey-a sub-analysis of a survey with 21 050 patients in 26 countries worldwide. Cardiovasc J Afr. 2010;21(4):200-5.
Biológicos "Carlos J. Finlay" [homepage en Internet]; diciembre 2010 [citado 18 de diciembre de 2010]. Disponible en: http://www.biofinlay.sld.cu
Herrera R, Almaguer M, Chipi J, Martínez O, et al. Albuminuria as a Marker of Kidney and Cardio-cerebral Vascular Damage. Isle of Youth Study (ISYS), Cuba. MEDICC Review. 2010;12(4):20-6.
Danziger J. Importance of Low-Grade Albuminuria. Mayo Clin Proc. 2008;83(7):806-12.
Campaña Nacional del Día Mundial del Riñón 2010. Microalbuminuria en pacientes adultos ambulatorios sin control nefrológico y con factores de riesgo de enfermedad renal crónica en Servicios de Nefrología de Perú. Nefrología. 2012;32(2):180-6.
Duman D, Demirtunç R, Karada B, Karatafl M. Association of albuminuria with impaired aortic elasticity and left ventricular diastolic dysfunction in type 2 diabetes. Anadolu Kardiyol Derg. 2008;8:5-10.
Sharma K. The link between obesity and microalbuminuria: adiponectina and podocyte dysfunction. Kidney Int. 2009;76:145-8.
Ariceta G. Proteinuria. Eur J Pediatr. 2011;170:15-20.
Iseki K, Iseki C, Kinjo K. C-Reactive Protein Is a Predictor for Developing Proteinuria in a Screened Cohort. Nephron Clin Pract. 2011;117:51-6.
Tsuneo K, Zhimei H, Satoshi T, Hiroshi A, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51-5.
Weisinger JR, Kempson RL, Elridge L, Senson RS. The nephritic syndrome: a complication of massive obesity. Ann Intern Med. 1974;81:440-7.
Cohen AH. Massive obesity and the kidney. A morphologic and statistical study. Am J Patthol. 1975;81:117-30.
Praga M, Hernández E, Morales E, Pérez A, Valero M, Martínez M, León M. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001;16:1790-8.
Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr. 2001;138:481-5.
Esquivel M, Rubí A. Curvas nacionales de peso para la talla. Rev Cubana Pediatr. 1995;57:377.
Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, et al. Prevalence and determinants of microalbuminuria in high risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care. 2000;23(2):35-9.
Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes. 1998;47:793-800.
Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens. 2009;18:246-51.
Burgert TS, Dziura J, Yeckel C, Taksali SE, Weiss R, Tamborlane W, Carpio S. Microalbuminuria in pediatric obesity: prevalence and relation to the other cardiovascular risk factors. International Journal of Obesity. 2006;30:273-80.
Savino A, Pelliccia P, Chiarelli F, Mohn A. Obesity-Related Renal Injury in Childhood. Horm Res Paediatr. 2010;73:303-11.
Piñeiro R, Callejas K, Pacheco L, Duarte M, Valdés M, Martínez R. Microalbuminuria en adolescentes obesos. Rev Cubana Pediatr [serie en Internet]. 2009 Jun [citado 12 de enero de 2011];81(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312009000200006&lng=es&nrm=iso&tlng=es
Herrera R. Obesidad y Enfermedad renal crónica. En: Alfonso J. Obesidad. Epidemia del siglo XXI. La Habana: Editorial Científico Técnica; 2008. p. 231-49.
Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362:485-93.
Fowler S, Kon V, Ma L, Richards W, Fogo A, Hunley T. Obesity related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescents after bariatric surgery. Pediatr Nephrol. 2009;24:851-5.
Bomback A, Klemmer P. Interaction of aldosterone and extracellular volume in the pathogenesis of obesity associated kidney disease: a narrative review. Am J Nephrol. 2009;30:140-6.
Serra A, Romero R, Lopez D, Navarro M, Esteve A, Perez N, Alastrue A, Ariza A. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947-55.
Serra A, Romero R. La obesidad como causa de enfermedad renal. Revista española de obesidad. 2009;7(4):113-6.